Press release
Biobanking Market to Hit USD 140.38 Bn by 2034?
The biobanking market plays a vital role in the healthcare and life sciences industry by providing essential biological samples for medical research, drug discovery, and personalized medicine. Biobanks store and manage human, animal, or plant biological materials like blood, tissues, DNA, and cells. They ensure that high-quality samples are preserved under strict standards for future use in various applications such as regenerative medicine, clinical research, and forensics. With continuous advancements in biotechnology and increased awareness about personalized healthcare, the demand for efficient biobanking systems continues to surge globally, driving the expansion of this crucial market.
Biobanking Market Size
The biobanking market reached a substantial size of USD 72.10 Billion in 2024, showcasing its expanding significance in the global healthcare and research ecosystem. Biobanks have become instrumental in storing and supplying high-quality biospecimens to support breakthroughs in medicine and science. This strong market base reflects growing investments by pharmaceutical companies, research organizations, and academic institutions. With the increasing adoption of precision medicine and the surge in chronic diseases worldwide, the market size is anticipated to grow robustly. The biobanking sector's vast size underscores its indispensable role in the development of innovative therapies and advanced diagnostics, transforming how diseases are treated and prevented.
Get a Free Sample Report with Table of Contents - https://bitl.to/4oFI
Biobanking Market Trends
Several transformative trends are shaping the future of the biobanking market. One of the prominent trends is the integration of advanced automation and artificial intelligence to streamline sample storage and retrieval processes. Automation minimizes human error and ensures sample integrity, while AI facilitates efficient data management and analysis. Another trend gaining traction is the shift toward population-based biobanks to enable large-scale epidemiological studies and personalized medicine. The increasing focus on ethical biobanking practices, data privacy, and informed consent has become a crucial factor influencing market operations. Moreover, collaborations between biobanks and pharmaceutical firms are expanding the scope of precision medicine, creating new pathways for market growth.
Biobanking Market Opportunities and Challenges
The biobanking market holds vast opportunities driven by rapid technological advancements and growing investments in genomic research. The rise of regenerative medicine and personalized therapies demands large and diverse sample repositories, opening new growth avenues for biobanks globally. Emerging markets in Asia Pacific and Latin America present lucrative opportunities due to growing research infrastructure and favorable government initiatives. However, the industry faces significant challenges, including ethical concerns regarding consent and data usage, stringent regulatory requirements, and high operational costs for storage and maintenance. Addressing these challenges will be critical for stakeholders to harness the market's full potential and maintain long-term sustainability.
Biobanking Market Segmentation
By Material
Population-based Biobanks
Disease-based Biobanks
Academic Biobanks
Hospital-based Biobanks
Commercial Biobanks
By Sample Type
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Others
By Application
Drug Discovery and Development
Personalized Medicine
Regenerative Medicine
Clinical Research
Forensics
Others
By Ownership
Public Biobanks
Private Biobanks
Hybrid Biobanks
By Source
Human Biobanks
Animal Biobanks
Plant Biobanks
By End User
Biopharmaceutical Companies
Research and Academic Institutes
Hospitals
Contract Research Organizations (CROs)
Others
By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Read Full Report with Table of Contents - https://bitl.to/3tAh
Biobanking Market Growth
The biobanking market is witnessing remarkable growth driven by increasing investments in biomedical research and the rising demand for personalized healthcare solutions. Technological innovations such as automation, robotic sample handling, and sophisticated data management systems have streamlined biobanking operations, enhancing efficiency and scalability. Additionally, collaborations between public and private institutions are fostering the development of large-scale biobanks that support advanced clinical trials and drug development processes. As healthcare providers increasingly adopt precision medicine, the need for high-quality biospecimens has surged. This upward trajectory highlights the vital role biobanks play in transforming research capabilities and accelerating the development of next-generation treatments worldwide.
Biobanking Market Forecast
Looking ahead, the biobanking market is projected to grow at a CAGR of 6.89% during the forecast period of 2025-2034, reaching a value of USD 140.38 Billion by 2034. This promising forecast reflects the rising integration of big data and genomics into medical research. Continued investment in biobanking infrastructure, especially in emerging economies, will expand the availability of diverse sample collections. Growing awareness about biobanks' contribution to rare disease research and forensic science will further drive demand. Additionally, the evolution of virtual biobanking and cloud-based storage solutions is expected to reshape how biospecimens and associated data are managed, enabling secure, efficient, and remote access to valuable samples.
Biobanking Market Competitor Analysis
Thermo Fisher Scientific Inc.: Global leader providing advanced laboratory equipment, biobanking storage solutions, and sample management systems to support biomedical research.
Brooks Automation, Inc.: Specializes in automated storage systems and sample management technologies, enhancing efficiency and security in modern biobanking facilities worldwide.
Qiagen N.V.: Offers innovative molecular sample technologies, enabling efficient collection, processing, and analysis of biological specimens for research and diagnostics.
Tecan Group Ltd.: Develops precision laboratory automation and liquid handling instruments, supporting high-throughput biobanking workflows for research institutions.
Hamilton Company: Provides automated sample storage, liquid handling, and robotics solutions for secure and scalable biobanking operations.
Chart Industries, Inc.: Designs cryogenic storage equipment and solutions, ensuring long-term preservation of biological samples at ultra-low temperatures.
PHC Holdings Corporation: Supplies biomedical freezers and storage equipment, supporting safe storage and transport of critical biospecimens for biobanking.
Becton, Dickinson and Company (BD): Leading supplier of medical devices and laboratory solutions, including sample collection and storage systems for biobanks.
Merck KGaA: Offers a wide range of life science tools and services, supporting biobanking, genomics, and drug discovery processes globally.
Panasonic Healthcare Holdings Co., Ltd.: Manufactures high-performance ultra-low temperature freezers and biomedical storage solutions for reliable sample preservation.
STEMCELL Technologies Inc.: Provides specialized cell culture media, reagents, and tools essential for regenerative medicine and advanced biobanking research.
Lifenet Health: Non-profit leader in human tissue banking and regenerative medicine, providing high-quality tissue samples for research and transplantation.
Promega Corporation: Delivers genomic, protein, and cellular analysis tools, enabling biobanks to maximize sample utility in life sciences research.
Greiner Bio-One International GmbH: Produces high-quality laboratory and medical devices, including advanced sample collection and storage products for biobanking.
Lonza Group AG: Supplies bioprocessing solutions, cell therapy services, and storage technologies that support efficient sample management for biobanks worldwide.
Read More Report
Sickle Cell Disease Treatment Market - https://bitl.to/4oFJ
Recombinant DNA Technology Market - https://bitl.to/4oFL
Healthcare Cloud Computing Market - https://bitl.to/3sFJ
Media Contact
Company Name: Claight Corporation
Contact Person: Lalit Sen, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biobanking Market to Hit USD 140.38 Bn by 2034? here
News-ID: 4094099 • Views: …
More Releases from Expert Market Research
United States Webcam Market Size, Growth & Trends 2025-2034
The United States webcam market has experienced substantial growth in recent years, fueled by the increasing demand for high-quality video communication tools. Webcams, which were once primarily used for video conferencing, have become essential for various applications, including content creation, gaming, online education, and telehealth. The widespread adoption of remote work and digital learning has further accelerated the growth of this market.
In 2024, the U.S. webcam market was valued at…
Precision Medicine Market: A Deep Dive into Its Evolving Landscape
The precision medicine market represents one of the most transformative shifts in modern healthcare. Instead of relying on generalized treatments that assume all patients respond similarly, precision medicine leverages biological, genetic, and lifestyle data to deliver interventions tailored to the individual. This personalized approach is reshaping how diseases are prevented, diagnosed, and managed. Its importance continues to grow as healthcare systems seek more efficient, patient-centered solutions capable of improving outcomes…
Global Industrial Hemp Market: Growth, Trends, and Future Outlook 2034
The global industrial hemp market is on a rapid growth trajectory. In 2024, the market size is expected to reach approximately USD 5.99 billion, and it's projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period from 2025 to 2034. By 2034, the market is set to reach an impressive value of USD 34.16 billion. This growth is driven by the increasing demand for…
Laboratory Information System Market Hits $2.1B, 9% CAGR
Why Is the Laboratory Information System Market Growing So Rapidly in 2024-2034?
The laboratory information system market is undergoing significant expansion due to increasing digitalization in healthcare and growing demand for efficient diagnostic workflow management. As laboratories face rising testing volumes, stricter regulatory requirements, and a growing need for automated sample tracking, the adoption of LIS platforms has accelerated globally.
In 2024, the market reached USD 2.10 Billion, and with a robust…
More Releases for Biobanks
Biobanks Market Demand, Survey, Forecast 2028
According to Premium Market Insights new research study on "biobanks market is projected to reach US$ 3,758.64 million by 2028 from US$ 2,418.31 million in 2021; it is expected to grow at a CAGR of 6.5% during 2021-2028.
Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00073331/?utm_source=OpenPR&utm_medium=10655
Some Of the Major Players Influencing are THERMO FISHER SCIENTIFIC INC., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., MICRONICS JAPAN CO., LTD., BD, Taylor-Wharton, Brooks…
Electronic Health Records (EHR) To Catalyse The Biobanks Market
Biobanks refers to the repository that collects, stores and distributes human biological materials including blood, plasma, saliva, purified DNA and other biospecimens. Biological banks keep a record of personal and health related information such as genetic information, health records, lifestyle, and family history for use it in health and medical research.
Biological materials are stored in biobanks in an appropriate environment. It helps to detect human diseases and their causes; by…
South America Biobanks Market Growth Factors, Opportunities, Ongoing Trends
The biobanks market in South America is expected to grow from US$ 190.08 million in 2021 to US$ 261.23 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.
South America Biobanks Market study by "The Business Market Insights" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive…
Biobanks Market - Product Growth Strategies 2025 | BioCision, Tecan Group
Global Biobanks Market: Snapshot
Biobanks are essentially repositories for storing biological substances derived from humans, which may include organs, bio-specimens, plasma, saliva, and blood. With a vast rise in the number of organ replacement surgeries globally and significant advancements made in the fields of transfusion and replacement technologies, the role of the biobanks market has become more concrete in the healthcare sector in recent years.
The global biobanks market has witnessed expansion…
Biobanks Market Explores New Growth Opportunities By 2020
Biobanks refers to the repository that collects, stores and distributes human biological materials including blood, plasma, saliva, purified DNA and other biospecimens. Biological banks keep a record of personal and health related information such as genetic information, health records, lifestyle, and family history for use it in health and medical research. Biological materials are stored in biobanks in an appropriate environment.
To view complete report @ http://www.persistencemarketresearch.com/market-research/biobanks-market.asp
It helps to detect human…
Biobanks Market: Industry Survey and Outlook 2025
Global Biobanks Market: Overview
The global biobanks market owes its conception to the rising need for replacement organs and the steady advancement in the replacement and transfusion technologies regarding a number of bodily substances. Though the technology and need to store organs and other bio-entities had been available for a long time, the global biobanks market took on a more important role in the healthcare sector following the increasing research in…
